MannKind (MNKD) Stock Price, Quote, News & History

SPY777.29−0.16%QQQ743.86−0.99%BTC/USD81,349.00−0.47%DIA518.08+0.38%GLD382.24−0.61%TLT77.97−0.01%

Premium

MannKind Corp (MNKD) Stock Price, Quote, News & History

MNKDNASDAQ

Trade with Public

$3.13

-0.16-4.86%

Last update: Oct 12, 5:20 PM

$3.18

-0.11-3.4%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$3.24

$3.13

Volume / Avg.

3.96M / 4.49M

Day Range

$3.18 - $3.18

52 Wk Range

2.23 - 6.51

Market Cap

$1.06B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.24%

Days to Cover

4.44

Recent MannKind Corporation News

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

MannKind licenses Technosphere GLP-1 tech to Rose Pharma for weight management development.

Vandana Singh

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

MannKind stock rose after the FDA approved Furoscix ReadyFlow, as the company also announced a $50 million private placement financing.

Vandana Singh

Jim Cramer Puts This Chip Stock In The 'Penalty Box,' Warns Occidental Could 'Go Down A Lot' If War Ends

Cramer put Photronics in the penalty box due to poor results. He praised Woodward and warned against Occidental Petroleum.

Avi Kapoor

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures up, Dow futures gain 0.1% as Snap (NYSE: SNAP) shares fall 10.5%, Fastly (NASDAQ: FSLY) down 21.6%, and other stocks decline in pre-market trading.

Avi Kapoor

Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised guidance. Other gaining stocks include EVC, BLMN, MNKD, FLEX, HUT, AVTX, COMP, VCYT, and SSRM.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-8.05M

Investing Cash Flow (TTM)

-280.39M

Financing Cash Flow (TTM)

284.37M

Free Cash Flow (TTM)

-18.14M

Capital Expenditure (TTM)

-10.08M

Net Change in Cash (TTM)

-4.07M

Analyst Trends and Forecast

Jul

Aug

Sep

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.28B

PE Ratio (TTM)

PE Ratio (FWD)

25.32

PEG Ratio (TTM)

PS Ratio (TTM)

2.61

PB Ratio (TTM)

Earnings Yield % (TTM)

-4.56%

Earnings Yield % (FWD)

3.95%

EV / EBITDA (TTM)

62.72

Price / EBITDA (TTM)

50.44

Price / Free Cash Flow (TTM)

Book Value / Share

-$0.21

Company Debt

Total Debt

$319.08M

LT Debt

$319.08M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$35.50M

Total Cash

$52.93M

Debt to Equity

Issuance of Debt (TTM)

$289.50M

Repayment of Debt (TTM)

-$35.50M

Key Statistics

Open

$3.24

$3.13

Volume / Avg.

3.96M / 4.49M

Day Range

$3.18 - $3.18

52 Wk Range

2.23 - 6.51

Market Cap

$1.06B

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

8.24%

Days to Cover

4.44

About MannKind Corp

Sector

Health Care

Industry

Biotechnology

MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

How do I buy MannKind (MNKD) stock?

You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.

View our list of the best stock brokerages

Who are MannKind (MNKD) competitors?

Other companies in MannKind’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).

What is the forecast, or price target, for MannKind (MNKD) stock?

MannKind has a consensus price target of $9.05.

What is the current price for MannKind (MNKD)?

The stock price for MannKind (NASDAQ: MNKD) is $3.178 last updated October 12, 2026 at 5:20 PM EDT.

Does MannKind (MNKD) pay a dividend?

There are no upcoming dividends for MannKind.

When is MannKind (NASDAQ:MNKD) reporting earnings?

MannKind does not have any upcoming earnings scheduled.

Is MannKind (MNKD) going to split?

There is no upcoming split for MannKind.

What sector and industry does MannKind (MNKD) operate in?

MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MannKind Corp (MNKD) Stock Price, Quote, News & History

MannKind (MNKD) Stock Price, Quote, News & History | Benzinga

Key Statistics

Recent MannKind Corporation News

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

Jim Cramer Puts This Chip Stock In The 'Penalty Box,' Warns Occidental Could 'Go Down A Lot' If War Ends

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About MannKind Corp

Edge Rankings

Stock Score Locked: Want to See it?

FAQ

How do I buy MannKind (MNKD) stock?

Who are MannKind (MNKD) competitors?

What is the forecast, or price target, for MannKind (MNKD) stock?

What is the current price for MannKind (MNKD)?

Does MannKind (MNKD) pay a dividend?

When is MannKind (NASDAQ:MNKD) reporting earnings?

Is MannKind (MNKD) going to split?

What sector and industry does MannKind (MNKD) operate in?

Key Statistics

Recent MannKind Corporation News

Breathing In GLP-1: MannKind Partners With Rose Pharma for Inhaled Weight Management Molecule

FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease

Jim Cramer Puts This Chip Stock In The 'Penalty Box,' Warns Occidental Could 'Go Down A Lot' If War Ends

Snap, Whirlpool, Nerdwallet And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday

Financials

Cash Flows

Analyst Trends and Forecast

Analyst Rating and Forecast

Valuation Metrics

Company Debt

Key Statistics

About MannKind Corp

Edge Rankings

Stock Score Locked: Want to See it?

Bulls vs Bears

FAQ

How do I buy MannKind (MNKD) stock?

Who are MannKind (MNKD) competitors?

What is the forecast, or price target, for MannKind (MNKD) stock?

What is the current price for MannKind (MNKD)?

Does MannKind (MNKD) pay a dividend?

When is MannKind (NASDAQ:MNKD) reporting earnings?

Is MannKind (MNKD) going to split?

What sector and industry does MannKind (MNKD) operate in?

Bulls vs Bears